0 01/12/2023 30/11/2024 2024-11-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-12-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 14474044 2023-12-01 2024-11-30 14474044 2024-11-30 14474044 2023-11-30 14474044 2022-12-01 2023-11-30 14474044 2023-11-30 14474044 2022-11-30 14474044 bus:Director1 2023-12-01 2024-11-30 14474044 core:WithinOneYear 2024-11-30 14474044 core:WithinOneYear 2023-11-30 14474044 bus:Micro-entities 2023-12-01 2024-11-30 14474044 bus:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 14474044 bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 14474044 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 14474044 bus:FullAccounts 2023-12-01 2024-11-30
Company registration number: 14474044
Diabi Revive limited
Unaudited filleted financial statements
30 November 2024
Diabi Revive limited
Contents
Statement of financial position
Diabi Revive limited
Statement of financial position
30 November 2024
30/11/24 30/11/23
£ £
Fixed assets 12,957 15,243
_______ _______
Current assets 21,546 29,913
Creditors: amounts falling due within one year ( 34,785) ( 30,828)
_______ _______
Net current liabilities ( 13,239) ( 915)
_______ _______
Total assets less current liabilities ( 282) 14,328
Accruals and deferred income ( 1,220) ( 1,000)
_______ _______
Net (liabilities)/assets ( 1,502) 13,328
_______ _______
Capital and reserves ( 1,502) 13,328
_______ _______
Diabi Revive limited
Year ended 30 November 2024
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 27 August 2025 , and are signed on behalf of the board by:
Dr Christopher Hale
Director
Company registration number: 14474044
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is 2nd Floor College House, 17 King Edwards Road, Ruislip, London, HA4 7AE.